MABGEL 1 : C2F5, C4E10 & C2G12 as a vaginal microbicide
Topical microbicides are being developed as a female-controlled method for preventing HIV-1 infection. Non-antiretroviral (ARV)-based candidates may be advantageous given increasing levels of ARV resistance in low and middle- income countries. MABGEL 1 was a phase 1 trial designed to evaluate the ph...
| Main Author: | |
|---|---|
| Published: |
University of Hull
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.587007 |